Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Pierre van Damme

Showing results (121-130 of 365) with videos related to

Pageof 37
Sort By:
Journal of Viral Hepatitis|October 4, 2023
The elimination of hepatitis D as a public health problem: Needs and challengesThomas Vanwolleghem, Paige A Armstrong, Maria Buti, et al.
Vaccine|May 17, 2011
Impact of rotavirus vaccination on laboratory confirmed cases in BelgiumGermaine Hanquet, Geneviève Ducoffre, Anne Vergison, et al.
Vaccine|May 15, 2003
Seroprevalence of Bordetella pertussis antibodies in Flanders (Belgium)Marie Van der Wielen, Pierre Van Damme, Koen Van Herck, et al.
Vaccine|May 5, 2016
Pertussis vaccination during pregnancy in Belgium: Follow-up of infants until 1 month after the fourth infant pertussis vaccination at 15 months of ageKirsten Maertens, Raïssa Nadège Caboré, Kris Huygen, et al.
Human Vaccines & Immunotherapeutics|June 30, 2021
The intent of students to vaccinate is influenced by cultural factors, peer network, and knowledge about vaccinesLaura Chinenye Ilogu, Olga Lugovska, Ivo Vojtek, et al.
Vaccine|September 9, 2019
Clinical trials with GMO-containing vaccines in Europe: Status and regulatory frameworkFlorence Kauffmann, Pierre Van Damme, Geert Leroux-Roels, et al.
Vaccine|July 21, 2015
Long-term antibody persistence after vaccination with a 2-dose Havrix (inactivated hepatitis A vaccine): 20 years of observed data, and long-term model-based predictionsHeidi Theeten, Koen Van Herck, Olivier Van Der Meeren, et al.
Plos One|July 28, 2020
Early detection of chronic hepatitis B and risk factor assessment in Turkish migrants, Middle Limburg, BelgiumÖzgür M Koc, Cécile Kremer, Niel Hens, et al.
Journal of Virus Eradication|April 10, 2024
Opportunistic screening using point-of-care testing leads to successful linkage to care of HBV-infected migrant populations in a low endemic countryErwin Ho, Axelle Vanderlinden, Liesbeth Govaerts, et al.
Vaccine|February 2, 2021
One or two doses of hepatitis A vaccine in universal vaccination programs in children in 2020: A systematic reviewAnar Andani, Pierre van Damme, Eveline M Bunge, et al.
Pageof 37

Showing results (121-130 of 365) with videos related to

Sort By:
Pageof 37
Journal of Viral Hepatitis|October 4, 2023
The elimination of hepatitis D as a public health problem: Needs and challengesThomas Vanwolleghem, Paige A Armstrong, Maria Buti, et al.
Vaccine|May 17, 2011
Impact of rotavirus vaccination on laboratory confirmed cases in BelgiumGermaine Hanquet, Geneviève Ducoffre, Anne Vergison, et al.
Vaccine|May 15, 2003
Seroprevalence of Bordetella pertussis antibodies in Flanders (Belgium)Marie Van der Wielen, Pierre Van Damme, Koen Van Herck, et al.
Vaccine|May 5, 2016
Pertussis vaccination during pregnancy in Belgium: Follow-up of infants until 1 month after the fourth infant pertussis vaccination at 15 months of ageKirsten Maertens, Raïssa Nadège Caboré, Kris Huygen, et al.
Human Vaccines & Immunotherapeutics|June 30, 2021
The intent of students to vaccinate is influenced by cultural factors, peer network, and knowledge about vaccinesLaura Chinenye Ilogu, Olga Lugovska, Ivo Vojtek, et al.
Vaccine|September 9, 2019
Clinical trials with GMO-containing vaccines in Europe: Status and regulatory frameworkFlorence Kauffmann, Pierre Van Damme, Geert Leroux-Roels, et al.
Vaccine|July 21, 2015
Long-term antibody persistence after vaccination with a 2-dose Havrix (inactivated hepatitis A vaccine): 20 years of observed data, and long-term model-based predictionsHeidi Theeten, Koen Van Herck, Olivier Van Der Meeren, et al.
Plos One|July 28, 2020
Early detection of chronic hepatitis B and risk factor assessment in Turkish migrants, Middle Limburg, BelgiumÖzgür M Koc, Cécile Kremer, Niel Hens, et al.
Journal of Virus Eradication|April 10, 2024
Opportunistic screening using point-of-care testing leads to successful linkage to care of HBV-infected migrant populations in a low endemic countryErwin Ho, Axelle Vanderlinden, Liesbeth Govaerts, et al.
Vaccine|February 2, 2021
One or two doses of hepatitis A vaccine in universal vaccination programs in children in 2020: A systematic reviewAnar Andani, Pierre van Damme, Eveline M Bunge, et al.
Pageof 37